Daner Li

923 total citations
16 papers, 519 citations indexed

About

Daner Li is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Daner Li has authored 16 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Genetics. Recurrent topics in Daner Li's work include HIV/AIDS Research and Interventions (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). Daner Li is often cited by papers focused on HIV/AIDS Research and Interventions (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). Daner Li collaborates with scholars based in United States, Puerto Rico and Denmark. Daner Li's co-authors include Bruce Thompson, D. Heather Watts, Ruth Tuomala, Mark Vajaranant, Sheldon H. Landesman, Hunter Hammill, Jane Pitt, Carmen Zorrilla, Andrew H. Limper and MeiLan K. Han and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PEDIATRICS.

In The Last Decade

Daner Li

16 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daner Li United States 11 249 137 135 95 64 16 519
Eric M. Maiese United States 13 163 0.7× 68 0.5× 57 0.4× 60 0.6× 18 0.3× 43 580
M. Hafizur Rahman United States 10 233 0.9× 51 0.4× 163 1.2× 90 0.9× 41 0.6× 15 676
Thomas Discher Germany 9 101 0.4× 60 0.4× 174 1.3× 106 1.1× 16 0.3× 24 407
Célestin Danwang Cameroon 14 187 0.8× 44 0.3× 78 0.6× 128 1.3× 84 1.3× 44 606
Max Kroon South Africa 14 295 1.2× 40 0.3× 100 0.7× 164 1.7× 72 1.1× 36 723
E. Pannier France 16 264 1.1× 47 0.3× 78 0.6× 260 2.7× 198 3.1× 44 880
Cindy Garris United States 16 351 1.4× 99 0.7× 92 0.7× 118 1.2× 18 0.3× 47 841
Stefano Rinaldi Italy 18 216 0.9× 59 0.4× 96 0.7× 198 2.1× 25 0.4× 57 867
Lindsey L. Wolf United States 15 122 0.5× 69 0.5× 145 1.1× 111 1.2× 90 1.4× 36 703
Ann‐Britt Bohlin Sweden 12 163 0.7× 58 0.4× 38 0.3× 65 0.7× 94 1.5× 19 423

Countries citing papers authored by Daner Li

Since Specialization
Citations

This map shows the geographic impact of Daner Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daner Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daner Li more than expected).

Fields of papers citing papers by Daner Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daner Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daner Li. The network helps show where Daner Li may publish in the future.

Co-authorship network of co-authors of Daner Li

This figure shows the co-authorship network connecting the top 25 collaborators of Daner Li. A scholar is included among the top collaborators of Daner Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daner Li. Daner Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Catenacci, Daniel V.T., Haeseong Park, Hope E. Uronis, et al.. (2018). Margetuximab (M) plus pembrolizumab (P) in ERBB2-amplified PD-L1+ gastroesophageal adenocarcinoma (GEA) post trastuzumab (T).. Journal of Clinical Oncology. 36(15_suppl). 4030–4030. 12 indexed citations
2.
3.
Vesikari, Timo, Markus Maeurer, Raija Ahmed, et al.. (2017). Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials. Vaccine. 35(12). 1652–1661. 41 indexed citations
4.
5.
Kruk, Mariusz, Venu Menon, Jacek Kądziela, et al.. (2013). Impact of percutaneous coronary intervention on biomarker levels in patients in the subacute phase following myocardial infarction: the Occluded Artery Trial (OAT) biomarker ancillary study. BMC Cardiovascular Disorders. 13(1). 91–91. 6 indexed citations
6.
Berry, Cristine E., Michael Drummond, MeiLan K. Han, et al.. (2012). Relationship Between Lung Function Impairment and Health-Related Quality of Life in COPD and Interstitial Lung Disease. CHEST Journal. 142(3). 704–711. 30 indexed citations
7.
Katz, Ingrid T., Roger Shapiro, Daner Li, et al.. (2010). Risk Factors for Detectable HIV-1 RNA at Delivery Among Women Receiving Highly Active Antiretroviral Therapy in the Women and Infants Transmission Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(1). 27–34. 32 indexed citations
8.
Miller, Scott T., Winfred C. Wang, Rathi V. Iyer, et al.. (2009). Urine concentrating ability in infants with sickle cell disease: Baseline data from the phase III trial of hydroxyurea (BABY HUG). Pediatric Blood & Cancer. 54(2). 265–268. 23 indexed citations
9.
Han, MeiLan K., Jeffrey J. Swigris, Brian J. Bartholmai, et al.. (2009). Gender influences health-related Quality of Life in IPF. Respiratory Medicine. 104(5). 724–730. 38 indexed citations
10.
Han, MeiLan K., Brian J. Bartholmai, Lyrica X. Liu, et al.. (2009). Clinical Significance of Radiologic Characterizations in COPD. COPD Journal of Chronic Obstructive Pulmonary Disease. 6(6). 459–467. 72 indexed citations
11.
Aldrovandi, Grace M., William T. Shearer, Daner Li, et al.. (2009). Antiretroviral Exposure and Lymphocyte mtDNA Content Among Uninfected Infants of HIV-1-Infected Women. PEDIATRICS. 124(6). e1189–e1197. 43 indexed citations
12.
Wynn, Lynn, Lane Faughnan, Daner Li, et al.. (2008). Recruitment of Infants with Sickle Cell Anemia to a Phase III Trial:Data from the BABY HUG Study.. Blood. 112(11). 1429–1429. 4 indexed citations
13.
Watts, D. Heather, Daner Li, Hugh H. Tilson, et al.. (2006). Assessment of Birth Defects According to Maternal Therapy Among Infants in the Women and Infants Transmission Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(3). 299–305. 41 indexed citations
14.
Tuomala, Ruth, D. Heather Watts, Daner Li, et al.. (2005). Improved Obstetric Outcomes and Few Maternal Toxicities Are Associated With Antiretroviral Therapy, Including Highly Active Antiretroviral Therapy During Pregnancy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 38(4). 449–473. 130 indexed citations
15.
Adams, Robert J., Julio C. Barredo, Duane R. Bonds, et al.. (2005). TCD in Infants: A Report from the BABY HUG Trial.. Blood. 106(11). 952–952. 4 indexed citations
16.
Rogers, Zora R., Winfred C. Wang, Daner Li, et al.. (2004). Evaluation of Splenic Function in Infants with Sickle Cell Anemia in the BABY HUG Trial.. Blood. 104(11). 3587–3587. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric M. Maiese Breakdown of academic impact, for papers by M. Hafizur Rahman Breakdown of academic impact, for papers by Thomas Discher Breakdown of academic impact, for papers by Célestin Danwang Breakdown of academic impact, for papers by Max Kroon Breakdown of academic impact, for papers by E. Pannier Breakdown of academic impact, for papers by Cindy Garris Breakdown of academic impact, for papers by Stefano Rinaldi Breakdown of academic impact, for papers by Lindsey L. Wolf Breakdown of academic impact, for papers by Ann‐Britt Bohlin
Rankless by CCL
2026